Angelalign Technology Inc. (SEHK: 6699)
Health Care · Health Care Equipment & Supplies · CN
HK$82.30
-1.08% today · +33.3% 1Y
Angelalign Technology Inc. (SEHK: 6699) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.79B and employs 4,478 people.
Over the last twelve months the share price has gained 33.3%, trading between 58.20 and 100.00.
Tweenvest scores Angelalign Technology Inc. across four factors: quality 71/100, value 72/100, growth 84/100, dividend 81/100. Its strongest factor is growth.
6699 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.79B
- Revenue (TTM)
- $439.63M
- P/E
- 43.72
- EPS
- 0.24
- Dividend yield
- 12.06%
- Beta (5Y)
- 1.20
- 52-week high
- HK$100.00
- 52-week low
- HK$58.20
- Avg volume (3M)
- —
- Shares outstanding
- 170.90M
- Employees
- 4,478
- Next earnings
- —
About Angelalign Technology Inc.
Angelalign Technology Inc. functions as an investment holding enterprise primarily dedicated to the innovation, production, and distribution of clear aligner solutions for orthodontic treatment throughout China. Their key offerings, Angel Aligner Pro and Angel Aligner Classic, are bespoke, removable clear aligners designed to gradually guide a patient's teeth into proper alignment over time. Beyond aligner development, the company also operates dental clinics that provide a variety of services, including orthodontics and cosmetic dentistry, and distributes intraoral scanners. Their extensive portfolio of clear aligner brands features Angelalign, Angelalign Pro, Angelalign Kid, and COMFOS. The firm was founded in 2003 and maintains its principal offices in Shanghai, China.
- ISIN
- KYG0405D1051
- Founded
- 2003
- Listed since
- Jun 16, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Establishment Labs Holdings Inc.NasdaqCM: ESTA | $1.84B | $60.30 | -2.22% |
| Implantica AGOM: IMP A SDB | $1.83B | Skr64.60 | -14.10% |
| Tofflon Science and Technology Group Co., Ltd.SZSE: 300171 | $1.81B | CN¥15.96 | -2.86% |
| Shandong Pharmaceutical Glass Co.LtdSHSE: 600529 | $1.81B | CN¥18.28 | +0.61% |
| Embla Medical hf.CPSE: EMBLA | $1.76B | Dkr27.65 | +3.95% |
| DENTSPLY SIRONA Inc.NasdaqGS: XRAY | $1.76B | $8.67 | -1.81% |
| Jafron Biomedical Co.,Ltd.SZSE: 300529 | $1.75B | CN¥15.12 | -0.98% |
| NovoCure LimitedNasdaqGS: NVCR | $1.70B | $14.66 | +0.55% |
Figures last refreshed Oct 11, 2026.